Why Top 3% Biotech Stock, Eton, Just Catapulted To A Record High

Eton banal catapulted to a grounds precocious Friday aft the biotech institution smashed second-quarter income forecasts and hiked its guidance for the year. The institution sells treatments for uncommon diseases and pediatric endocrinology. During the June quarter, Eton Pharmaceuticals (ETON) generated $37.6 cardinal successful sales. Sales skyrocketed 99% and handily bushed expectations for $27.1 million, according to FactSet. That led…